SCHEMBL4198174

SCHEMBL4198174

CC(O)c1ncc(F)cc1F

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.33
AGBL2 Q5U5Z8 1/20 0.33
CES2 O00748 2/20 0.30
CES1 P23141 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2737358 0.83 AGBL2 (0.32) AGBL2
SCHEMBL25991349 0.83 GABRG2 (0.32) AGBL2CES2CES1
SCHEMBL30318400 0.82 AGBL2 (0.43) APLNRAGBL2
SCHEMBL24123105 0.80 IDH1 (0.39)
SCHEMBL16224788 0.80 S1PR3 (0.41)
SCHEMBL34468435 0.80 APLNR (0.32) APLNRAGBL2
SCHEMBL30388688 0.80 IDH1 (0.39)
SCHEMBL588518 0.79 PDE2A (0.32) APLNRAGBL2
SCHEMBL588625 0.79 PDE2A (0.32) APLNRAGBL2
SCHEMBL22304409 0.79 AGBL2 (0.30) AGBL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119053588-A P38 alpha-MK 2 inhibitor compound, pharmaceutical composition and application thereof 长春金赛药业有限责任公司 2024-11-29 CN disclosed
WO-2009016410-A2 CHEMICAL COMPOUNDS 831 ASTRAZENECA AB (SE) 2009-02-05 WO disclosed
WO-2008132502-A1 PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-11-06 WO disclosed